SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 58 filers reported holding SESEN BIO INC in Q4 2020. The put-call ratio across all filers is 12.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $41,382 | +42.7% | 67,895 | 0.0% | 0.00% | – |
| Q3 2022 | $29,000 | -48.2% | 67,895 | 0.0% | 0.00% | – |
| Q2 2022 | $56,000 | -82.0% | 67,895 | -86.8% | 0.00% | – |
| Q1 2022 | $311,000 | -26.1% | 515,680 | 0.0% | 0.00% | – |
| Q4 2021 | $421,000 | +9.1% | 515,680 | +6.2% | 0.00% | – |
| Q3 2021 | $386,000 | -80.6% | 485,545 | +12.8% | 0.00% | -100.0% |
| Q2 2021 | $1,989,000 | +1253.1% | 430,374 | +663.7% | 0.00% | – |
| Q1 2021 | $147,000 | +90.9% | 56,356 | 0.0% | 0.00% | – |
| Q4 2020 | $77,000 | +381.2% | 56,356 | +412.3% | 0.00% | – |
| Q3 2020 | $16,000 | +100.0% | 11,000 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | +14.3% | 11,000 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -41.7% | 11,000 | 0.0% | 0.00% | – |
| Q4 2019 | $12,000 | -7.7% | 11,000 | 0.0% | 0.00% | – |
| Q3 2019 | $13,000 | -23.5% | 11,000 | 0.0% | 0.00% | – |
| Q2 2019 | $17,000 | -66.0% | 11,000 | -77.3% | 0.00% | – |
| Q1 2019 | $50,000 | – | 48,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 4,091,591 | $18,903,000 | 100.00% |
| Schonfeld Strategic Advisors LLC | 3,828,200 | $17,687,000 | 0.19% |
| Virtus ETF Advisers LLC | 52,632 | $243,000 | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 711,500 | $3,287,000 | 0.06% |
| WealthTrust Axiom LLC | 39,750 | $183,000 | 0.06% |
| CAXTON ASSOCIATES LP | 84,801 | $392,000 | 0.04% |
| Stratos Wealth Partners, LTD. | 352,500 | $1,629,000 | 0.04% |
| ClariVest Asset Management LLC | 260,500 | $1,203,000 | 0.04% |
| TWO SIGMA ADVISERS, LP | 2,766,318 | $12,780,000 | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 3,150,574 | $14,556,000 | 0.03% |